Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF&alpha; blocker failure

Código QR

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF&alpha; blocker failure

Joern Kekow,1 Ulf Mueller-Ladner,2 Hendrik Schulze-Koops31Clinic of Rheumatology and Orthopedics, Otto-von-Guericke University of Magdeburg, Vogelsang-Gommern; 2Department of Rheumatology and Clinical Immunology, Kerckhoff Clinic, Bad Nauheim; 3Division of Rheumatology, University of Munich, Munich,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kekow J, Mueller-Ladner U, Schulze-Koops H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/37d8e8927a8e4ddeb95b0c7b9042a8bd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers
por: Laine J, et al.
Publicado: (2016)

Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNF&alpha; therapy
por: Hubert Marotte, et al.
Publicado: (2008)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
por: E. A. Golikova, et al.
Publicado: (2012)

Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-&alpha; therapy for rheumatoid arthritis
por: Shu Kachi, et al.
Publicado: (2010)

Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis
por: Francesco Ursini, et al.
Publicado: (2017)

Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
por: Bounia CA, et al.
Publicado: (2021)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
por: Borja Hernández-Breijo, et al.
Publicado: (2021)

Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek population.
por: Maria I Zervou, et al.
Publicado: (2013)

Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Haralampos M Moutsopoulos, et al.
Publicado: (2008)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy H, et al.
Publicado: (2020)

Minocycline hydrochloride nanoliposomes inhibit the production of TNF-&alpha; in LPS-stimulated macrophages
por: Liu D, et al.
Publicado: (2012)

Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis.
por: Erik J M Toonen, et al.
Publicado: (2012)

Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis
por: Solveig K. Sieberts, et al.
Publicado: (2016)

Tumor necrosis factor-alpha (TNF-&alpha;) levels in aqueous humor of primary open angle glaucoma
por: Balaiya S, et al.
Publicado: (2011)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Joseph M Tuscano, et al.
Publicado: (2009)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: A. N. Silkov, et al.
Publicado: (2014)

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.
por: Kalle J Aaltonen, et al.
Publicado: (2012)

Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis
por: Solveig K. Sieberts, et al.
Publicado: (2016)

Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.
por: Jacob Sode, et al.
Publicado: (2014)

Probing the mechanical properties of TNF-&alpha; stimulated endothelial cell with atomic force microscopy
por: Sei-Young Lee, et al.
Publicado: (2011)

TNF-Α may mediate inflammasome activation in the absence of bacterial infection in more than one way.
por: Susana Álvarez, et al.
Publicado: (2013)

Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
por: Xiaofang Cui, et al.
Publicado: (2018)

Role of TNFα and IL-10 in rheumatoid arthritis and association with some HLA II DR and DQ alleles
por: N. Alsalih, et al.
Publicado: (2020)

High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
por: Elalouf O, et al.
Publicado: (2021)

Multiple imputation procedures allow the rescue of missing data: An application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapy
por: SCHIATTINO,IRENE, et al.
Publicado: (2005)

Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways
por: Kuninobu Wakabayashi, et al.
Publicado: (2008)

&alpha;-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy
por: Jungyeon Hwang, et al.
Publicado: (2008)

Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis
por: Sara Rahmati, et al.
Publicado: (2020)

Lentivirus-Mediated Overexpression or Silencing of Aquaporin 1 Affects the Proliferation, Migration and Invasion of TNF-α-Stimulated Rheumatoid Arthritis Fibroblast-Like Synoviocytes by Wnt/β-Catenin Signaling Pathway
por: Zhou MY, et al.
Publicado: (2021)

S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
por: Adéla Navrátilová, et al.
Publicado: (2021)

Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
por: Amel Rezgui, et al.
Publicado: (2021)

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
por: Re KA, et al.
Publicado: (2012)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci M, et al.
Publicado: (2013)

Inhibiting TNF-α signaling does not attenuate induction of endotoxin tolerance
por: Loosbroock C, et al.
Publicado: (2014)

Immunological strategy for detecting the pro-inflammatory cytokine TNF-alpha in salmonids
por: Rojas,Verónica, et al.
Publicado: (2012)

FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
por: Dawn L Cooper, et al.
Publicado: (2012)

miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization.
por: Noha Semaan, et al.
Publicado: (2011)

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
por: Lurati A, et al.
Publicado: (2013)

Russian forest sequesters substantially more carbon than previously reported
por: Dmitry Schepaschenko, et al.
Publicado: (2021)